Dr. Bettina Hamelin

President and CEO, Ontario Genomics

Dr. Bettina Hamelin is the President and CEO of Ontario Genomics. Before assuming her current role in August 2017, Bettina served as Vice-President of NSERC’s Research Partnerships Directorate, where she was responsible for a range of programs designed to stimulate increased public/private sector collaboration and technology transfer by connecting the Canadian research enterprise to Canadian and global innovation stakeholders. Bettina has more than 15 years of experience in the biotech and international pharmaceutical industry as well as 10 years of academic experience as a tenured professor at the Faculty of Pharmacy at Université Laval.

Prior to joining NSERC Bettina held a variety of leadership positions at Pfizer Canada, most recently as Canadian Medical Lead, Vaccines, and Head, Strategic Research Partnerships, Western Canada. She is passionate about bringing together unlikely partners to attract and leverage funds from diverse sources. She is known for pioneering novel public-private partnership models, and breaking down barriers between federal, provincial and private sector stakeholders.

Early roots in biology and chemistry (Vordiplom, Universität Kaiserslautern, Germany) have led Bettina to complete a B.Sc. in pharmacy and a Doctor of Pharmacy, both from the University of Kentucky, U.S. and an EMBA in Healthcare from the University of British Columbia, Canada.